Yuval Cohen

Chief Executive Officer

Yuval Cohen (Chief Executive Officer) filed 3 Form 4 reports in the trailing twelve months (0 purchases, 3 sales), most often in Corbus Pharmaceuticals Holdings, Inc. (CRBP). The largest single filing was $471K of CRBP (27,633 sh across 2 lots, as filed), executed Oct 24 2025.

Add to watchlist

Return, ttmiAverage return per filing, trailing twelve months

–

no purchases on file

Delay-adjustediThe same average, entered at disclosure dates

–

returns measure stock purchases only

Filings, ttm

0 buys · 3 sells

Median delay

–

execution → disclosure

Volume, ttmiDollar value disclosed in the trailing twelve months

$751K

shares × price, as filed

Last traded

Aug 7

Filed Aug 10

Median ADV $5.2M across their filed names

Open performance→

Volume by month

Buys $0 Sells $751K

Shares × price, as filed · by filing month · past 24 months

Sectors filed on

Healthcare 3 filings

Sector per market data · by filing · past 12 months

Most traded names

CRBP

Corbus Pharmaceuticals Holdings, Inc. CRBP · 0 buys · 3 sells 3 filings

Recent filings

CRBPSALE Corbus Pharmaceuticals Holdings, Inc. View filing → $171K
17,000 sh × $10.08
Exec Aug 7
Filed Aug 10 · 4:30 PM ET CRBPSALE Corbus Pharmaceuticals Holdings, Inc. View filing → $108K
13,871 sh × $7.78
Exec Feb 13
Filed Feb 18 · 5:30 PM ET CRBPSALE Corbus Pharmaceuticals Holdings, Inc. View filing → $471K
27,633 sh across 2 lots
Exec Oct 24 2025
Filed Oct 27 2025 · 5:30 PM ET